According to a report by Scoop Media on October 16, the Asia Pacific Association for Nicotine and Tobacco Harm Reduction Advocacy (CAPHRA) has issued a warning to the New Zealand government delegation attending the tenth session of the World Health Organization Framework Convention on Tobacco Control (FCTC COP10).
Government officials need to realize that their support for FCTC COP10 resolution could have a negative impact on the future of safer nicotine products, according to Nancy Loucas, the coordinator of CAPHRA, an advocate for harm reduction and public health policy expert.
Ms. Lucas stated, "The analysis by GSTHR confirms the significance of these decisions for the future of these products, but during the meeting, they were completely ignored." The publicly available briefing, titled "FCTC COP10 Agenda and Related Documents: The Impact on Tobacco Harm Reduction," reveals that safer nicotine products are seen as a threat to tobacco control rather than as tools to support smoking cessation and reduce high-risk tobacco use.
Mrs. Lucas stated that the development of safer nicotine products could potentially change the rules of the game in combating tobacco-related harm. However, the current narrative of FCTC COP10 does not reflect this possibility. Instead, they are perceived as a threat that could have serious implications for public health.
CAPHRA is urging the government and policymakers to consider the evidence presented in this briefing and recognize the potential of safer nicotine products as tools for harm reduction. "The decisions made at the FCTC COP10 conference will shape the future of tobacco harm reduction," added Ms. Lucas. "We urge all stakeholders to consider the evidence and make decisions prioritizing public health and harm reduction – the lives of consumers are at stake.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
